Literature DB >> 4326883

Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine.

M F Holick, H K Schnoes, H F DeLuca, T Suda, R J Cousins.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4326883     DOI: 10.1021/bi00790a023

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


× No keyword cloud information.
  67 in total

1.  Cutting Edge: AhR Is a Molecular Target of Calcitriol in Human T Cells.

Authors:  Mariko Takami; Kotaro Fujimaki; Michael I Nishimura; Makio Iwashima
Journal:  J Immunol       Date:  2015-08-14       Impact factor: 5.422

2.  Kinetic analysis of 25-hydroxyvitamin D3 metabolism in strontium-induced rickets in the chick.

Authors:  J L Omdahl; G Jelinek; R P Eaton
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

3.  Phosphate control and 25-hydroxycholecalciferol administration in preventing experimental renal osteodystrophy in the dog.

Authors:  W E Rutherford; P Bordier; P Marie; K Hruska; H Harter; A Greenwalt; J Blondin; J Haddad; N Bricker; E Slatopolsky
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

4.  Treatment of osteomalacia with oral 1-alpha-hydroxyvitamin D3 in a patient with malabsorption.

Authors:  J E Compston; L W Horton; J R Tighe
Journal:  Br Med J       Date:  1977-09-03

5.  1,25-Dihydroxyvitamin D3: mode of action in intestine and parathyroid glands, assay in humans and isolation of its glycoside from Solanum malacoxylon.

Authors:  M R Haussler; M R Hughes; T A McCain; J E Zerwekh; P F Brumbaugh; W Jubiz; R H Wasserman
Journal:  Calcif Tissue Res       Date:  1977-05

6.  Metabolism of 1,25-dihydroxycholecalciferol in the rat.

Authors:  C A Frolik; H F DeLuca
Journal:  J Clin Invest       Date:  1972-11       Impact factor: 14.808

7.  Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis.

Authors:  N H Bell; P H Stern; E Pantzer; T K Sinha; H F DeLuca
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

8.  Treatment of osteomalacia associated with primary biliary cirrhosis with parenteral vitamin D2 or oral 25-hydroxyvitamin D3.

Authors:  J E Compston; L W Horton; R P Thompson
Journal:  Gut       Date:  1979-02       Impact factor: 23.059

Review 9.  Calcitroic Acid-A Review.

Authors:  Olivia B Yu; Leggy A Arnold
Journal:  ACS Chem Biol       Date:  2016-09-06       Impact factor: 5.100

10.  De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxilase.

Authors:  Jeffrey B Cheng; Daniel L Motola; David J Mangelsdorf; David W Russell
Journal:  J Biol Chem       Date:  2003-07-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.